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Abstract
Background: In the last decade, several epidemiological studies have demonstrated the potential of using
seroprevalence (SP) and seroconversion rate (SCR) as informative indicators of malaria burden in low transmission
settings or in populations on the cusp of elimination. However, most of studies are designed to control ensuing
statistical inference over parasite rates and not on these alternative malaria burden measures. SP is in essence a
proportion and, thus, many methods exist for the respective sample size determination. In contrast, designing a
study where SCR is the primary endpoint, is not an easy task because precision and statistical power are affected by
the age distribution of a given population.
Methods: Two sample size calculators for SCR estimation are proposed. The first one consists of transforming the
confidence interval for SP into the corresponding one for SCR given a known seroreversion rate (SRR). The second
calculator extends the previous one to the most common situation where SRR is unknown. In this situation, data
simulation was used together with linear regression in order to study the expected relationship between sample
size and precision.
Results: The performance of the first sample size calculator was studied in terms of the coverage of the confidence
intervals for SCR. The results pointed out to eventual problems of under or over coverage for sample sizes ≤250 in
very low and high malaria transmission settings (SCR≤ 0.0036 and SCR≥ 0.29, respectively). The correct coverage
was obtained for the remaining transmission intensities with sample sizes ≥ 50. Sample size determination was
then carried out for cross-sectional surveys using realistic SCRs from past sero-epidemiological studies and typical
age distributions from African and non-African populations. For SCR < 0.058, African studies require a larger sample
size than their non-African counterparts in order to obtain the same precision. The opposite happens for the
remaining transmission intensities. With respect to the second sample size calculator, simulation unravelled the
likelihood of not having enough information to estimate SRR in low transmission settings (SCR≤ 0.0108). In that
case, the respective estimates tend to underestimate the true SCR. This problem is minimized by sample sizes of no
less than 500 individuals. The sample sizes determined by this second method highlighted the prior expectation
that, when SRR is not known, sample sizes are increased in relation to the situation of a known SRR. In contrast to
the first sample size calculation, African studies would now require lesser individuals than their counterparts
conducted elsewhere, irrespective of the transmission intensity.
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Conclusions: Although the proposed sample size calculators can be instrumental to design future cross-sectional
surveys, the choice of a particular sample size must be seen as a much broader exercise that involves weighting
statistical precision with ethical issues, available human and economic resources, and possible time constraints.
Moreover, if the sample size determination is carried out on varying transmission intensities, as done here, the
respective sample sizes can also be used in studies comparing sites with different malaria transmission intensities. In
conclusion, the proposed sample size calculators are a step towards the design of better sero-epidemiological studies.
Their basic ideas show promise to be applied to the planning of alternative sampling schemes that may target or
oversample specific age groups.
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Background
Parasite prevalence (PR) and entomological inoculation
rate (EIR) are the two most common disease risk indica-
tors used in malaria epidemiology. PR is defined as the
percentage of people who are currently infected with mal-
aria parasites, and reflects the direct interplay between
transmission intensity, age, and disease burden. EIR is in
turn the frequency at which people are bitten by infectious
mosquitoes over a period of time (typically a year), and
provides information on the vector biology and its inter-
action with the human host. These measures, although
useful in high and moderate transmission settings, show
limitations in areas of lower transmission or in popula-
tions on the cusp of disease elimination. This is primarily
due to the low number of infected individuals (humans or
mosquitoes) in the population at the time of sampling. Ac-
curate metrics are particularly important in assessing the
effects of malaria interventions at these low transmission
levels. Therefore, in recent years, alternative risk indicators
based on anti-malarial antibody seroprevalence (SP) and
seroconversion rate (SCR) have been evaluated [1-4].
The rationale of using antibody data stems from the ob-
servation that specific antibodies against parasite antigens
persist in time and at reasonably stable concentrations,
even when disease transmission is seasonal. Experimen-
tally, the quantification of antibodies in sera is relatively
easy to perform using simple laboratory techniques, such
as ELISA assays. The resulting antibody measurements
are usually optical densities or the respective titre values
upon which one classifies each individual as seronegative
or seropositive using appropriate cut-off points. These
seropositivity thresholds are typically determined by two
distinct approaches. The first one uses antibody data of
known seronegative individuals in which the parameters
of the underlying distribution are estimated, as illustrated
by Arnold et al. [5]. In contrast, the second approach is
based on fitting a Gaussian mixture model to current anti-
body data directly under the assumption that there are
two latent subpopulations referring to seronegative and
seropositive individuals, respectively [6]. In both ap-
proaches, the cut-off point for seropositivity is determined
by the average plus 3 times the standard deviation of the
seronegative population. Seroprevalence (SP) is then the
percentage of seropositive individuals in the sample and
embodies information over currently infected and recently
exposed individuals. As expected, SP estimates are typic-
ally higher than those for PR measured in the same sample
[1,7]. Although overcoming some of the shortcomings of
PR and EIR, SP does not reflect the dynamics of malaria
transmission directly.
Seroconversion rate (SCR) extends SP analysis to the
scenario where one is a step closer to capture the
underlying disease dynamics of a given population. This
serological parameter arises from the analysis of seropreva-
lence taken as function of age of the individuals using the
so-called reverse catalytic models. The age of individuals is
assumed to be a good surrogate of time in a stochastic
process where individuals transit between seropositive and
seronegative states upon malaria exposure and absence of
re-infection. Theoretically, SCR is defined as the frequency
by which seronegative individuals become seropositive upon
malaria exposure. Conversely the frequency by which sero-
positive individuals return to a seronegative state is known
as seroreversion rate (SRR). This last parameter is related to
antibody decay in absence of disease exposure and reflects
the effects of host factors on antibody dynamics.
Several studies have shown the utility of SCR as a
malaria epidemiological tool with some demonstrating
good agreement between this measure and EIR [1] and
others detecting historical changes in transmission that
otherwise would not have been possible with other
measures of transmission [4,7-9]. Whilst the evidence
for using serology as an adjunct epidemiological marker
for malaria transmission is growing, there has been no
formal examination of samples size considerations for
SP and SCR as primary endpoints. In fact, most malaria
epidemiological studies are planned with PR being as
the primary endpoint [7] and, therefore, it is unclear
whether SP and SCR might have enough statistical pre-
cision to lead to clear conclusions.
SP is in theory a proportion (or a percentage) and, as
such, several methods exist for sample size determination
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in this situation [10]. In contrast, the precision of SCR es-
timates depends not only on the sample size, but also on
the age distribution associated with a given population.
Therefore, sample size determination is not as straightfor-
ward. A pragmatic approach is to use an empirical rela-
tionship between SCR and SP in order to determine the
total sample size required for collecting a given number of
seropositive individuals [8]. This approach is here im-
proved by using the theoretical relationship between SP
and SCR under a given age distribution and a fixed
SRR. Sample size determination is then based on back-
transforming the confidence interval for SP into the corre-
sponding one for SCR. In the situation where SCR and
SRR are both unknown, a second sample size calculator is
developed by bringing simulation together with regression.
The use of these two sample size calculators is instrumen-
tal to power future serological studies, notably, in the chal-
lenging research settings of populations on the cusp of
elimination [11].
Methods
Reverse catalytic models for seropositivity data
In malaria epidemiology, the reverse catalytic models
were first described to estimate incidence and recovery
rates from longitudinal data [12]. More recently, they
were recast to the analysis of malaria seroprevalence
data [13]. Mathematically, these models can be
described as a Markov chain where individuals transit
between two serological states: 0 - seronegative and 1 -
seropositive. The time between transitions is assumed
to be exponentially distributed. This assumption im-
plies that every time an individual move from one state
to another, the stochastic process restarts probabilistic-
ally due to lack of memory of the Markov Chains.
This is in close agreement with the general notion that
malaria parasites can only confer partial immunity to
the host.
This paper deals with the simplest reverse catalytic
model where SCR and SRR are assumed to be fixed
constants throughout time and for every individual.
The use of this model has in practice three key implica-
tions. Firstly, a constant SCR implies that disease trans-
mission remained unchanged throughout time in the
population under study. Secondly, a constant SRR im-
plies that the host factors affecting antibody decay were
not altered by any genetic selection event, migration or
admixture. Thirdly, all individuals have experienced the
same disease transmission intensity and, thus, age can
be used as a surrogate of the time of disease dynamics.
Mathematically, the probability of individuals with age
t being at each serological state is given by the tran-
sition probability matrix P(t) = [pi|j(t)], i, j = 0, 1, where
pi|j(t) is the conditional probability of an individual
with age t being in state i given he started the process
in state j and R is the so-called rate matrix that, in turn,
is defined as
R ¼ −λ λ
ρ −ρ
 
; ð1Þ
where λ and ρ are the SCR and SRR, respectively. As-
suming that all individuals are born seronegative (that is,
seronegative at time t = 0; this is achieved in practice by
only including individuals aged or older than 1 year to
negate putative maternal effects on malaria antibodies),
the probability of an individual aged t being seropositive
is described by
p1j0 tð Þ ¼
λ
λþ ρ 1−e
− λþρð Þt
 
: ð2Þ
A special case of the above model may arise from
populations where only a few seronegative individuals
would result from seroreversion events. As a conse-
quence, data might not enough information to estimate
SRR (i.e., ρ ≈ 0). In this case, equation (2) can be rewrit-
ten as follows
log − log 1−p1j0 tð Þ
 h i
¼ logλþ log t: ð3Þ
This model has been applied to malaria data from low
transmission populations [14], to serology data on hu-
man leishmaniasis [15], and to limiting dilution data
[16]. Theoretically, equation (3) can be seen as the popu-
lar complementary log-log model from statistics that, in
turn, can be formulated as a generalized linear model
(GLM) under a binomial sampling scheme [17]. As such,
the respective parameter estimation can be performed in
most statistical softwares as long as one specifies 'log
age' as the explanatory variable and the corresponding
slope fixed at 1. Alternative sample size calculators for
this model could be used in the same line of a GLM
power analysis, as described elsewhere for logistic re-
gression [18,19].
There are also other reverse catalytic models describ-
ing changes in disease transmission (see, for example, re-
view of Corran et al. [1]). Although interesting, sample
size determination on these alternative models will be
studied elsewhere (Sepúlveda and Drakeley, in prepar-
ation). In malaria literature, one can also found an ex-
tension of the reverse catalytic modelling framework to
the situation where seropositivity can be boosted by re-
current malaria exposure [20]. This model would appear
to be more adequate to very high transmission settings
and, thus, out of the scope of this paper.
Model parameterization
To illustrate the sample size determination on realistic
values of SCR and SRR, Plasmodium falciparum data
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sets from two independent studies in northeast
Tanzania were used [3,21]. This region extends from
the high malaria transmission areas in the coastal
plains of Tanga to the low transmission settings in
the high altitude mountains of Kilimanjaro, Usambara
and Pare. Because of this natural variation in malaria
endemicity, northeast Tanzania is an ideal region to
understand how different malaria risk indicators are
related to each other. Available data of altitude (in
meters) against EIR [21] was re-analysed leading to the
following linear regression model (Additional file 1:
Figure A)
log10EIR ¼ 2:5204−0:0025 altitude: ð4Þ
In another epidemiological study, serological data from
21 villages of the same region was also available [3,13].
SCR associated with MSP1 antibodies was found to be
highly correlated with altitude [1]. This data set sug-
gested the following relationship between SCR and alti-
tude (Additional file 1: Figure B)
log10SCR ¼ −0:2908−0:0012 altitude; ð5Þ
where SRR estimate would appear to be constant across
villages and fixed at 0.017. In turn, data from the
same study suggested the following relationship between
PR of children aged 0–4 years old (PR04) and altitude
(Additional file 1: Figure C):
log
PR04
1‐PR04
¼ 8:9992−1:5934 log10altitude: ð6Þ
Solving one of the above equations as function of alti-
tude, the expected relationship between EIR, SCR, and
PR04 can be obtained as shown in Figure 1A.
Sample size determination was conducted on the
following transmission intensities as measured by EIR
and PR04 (in brackets) units: 0.01 (0.050), 0.1 (0.073), 1
(0.119), 10 (0.231) and 100 (0.625). The corresponding
SCRs are 0.0034, 0.0104, 0.0324, 0.0969 and 0.2900,
respectively (Table 1). With respect to the above-
mentioned large epidemiological study [1], a SCR
between 0.0034 and 0.0104 describes low transmission
intensities of high-altitude villages, such as Kilomeni
(1556 m - SCR = 0.0047) or Mokala (1702 m - SCR =
0.0104). SCRs between 0.01 and 0.10 are, in turn, asso-
ciated with villages in intermediate altitude, like Tewe
(1049 m - SCR = 0.0308) or Ngulu (831 m - SCR =
0.0906). Finally, SCRs greater than 0.10 are related to
lowland villages, such as Mgila (375 m - SCR = 0.128)
or Mgome (196 m - SCR = 0.302), where malaria trans-
mission is considered to be high. The expected age-
adjusted SP curves are shown in Figure 1B.
A B
C D
Figure 1 Model parameterization under the assumption of constant malaria transmission intensity: A. Expected relationship between
SCR, EIR rate and PR in children aged from 0 to 4 years olds. B. Age-adjusted SP curves given the expected SCRs associated with EIRs shown in A.
C. Age structure of African and non-African populations. D. Seroprevalence as function of SCR based on the age distributions shown in C.
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Model estimation
In terms of statistical analysis, age-adjusted seropositivity
data can be summarized as a frequency vector {nts}
where nts is the frequency of individuals with age t = 1,
…,T and serological state s = 0 or 1, T is the total number
of distinct age values in the sample. If individuals were
sampled independently of each other and the statistical
inference is focused on age-adjusted seroprevalence only,
the sampling distribution of the frequency vector {nts}
can be described by a binomial-product distribution, one
binomial distribution per age value, that is,
f ntsf gjλ; ρð Þ ¼
YT
t¼1
nt0 þ nt1ð Þ!
nt0!nt1!
p1j0 tð Þ
h int1
1−p1j0 tð Þ
h int0
;
ð7Þ
where p1|0(t) is given by equation (2). Parameter estima-
tion can be performed via standard maximum likelihood
methods, as described elsewhere [15]. Stata and R scripts
for parameter estimation are available from the authors
upon request.
Sample size calculations
The first sample size calculator assumes that SRR is a
known constant (say ρ0 = 0.017), thus, should not be es-
timated after sample collection. In that case, the ex-
pected relationship between SP of the population
(hereafter denoted by π) and SCR can be computed as
follows
π ¼
XAmax
t¼1
αt
λ
λþ ρ0
1−e− λþρ0ð Þt
 
; ð8Þ
where αt is the proportion of individuals aged t in the
population and Amax is the maximum age considered
relevant for the population, say Amax =80. As expected,
the above relationship depends on the age distribution
of the population (or of the study design used). Official
statistics on age distributions were explored in order to
understand how these vary across the world [22]. These
data sets suggest that African countries have the same
age distribution approximately (a decreasing frequency
from newborns to elderly; Additional file 2). Thus, a
typical age structure distribution for these populations
was generated by pooling data from different countries
together (Figure 1C). Although slight differences can be
observed across countries, the age distributions from
Southeast Asia and South America show roughly the
same pattern but distinct from the one for African popu-
lations (Additional file 2). Therefore, a non-African age
distribution prototype was constructed (Figure 1C). This
age structure is much flatter than its African counterpart
due to a higher frequency of adults.
These two general age distributions were then used to
derive the expected SP as function of SCR according to
equation (8) (see Figure 1D). Interestingly, the relation-
ship between SP and SCR in African populations when
SCR = 0 is similar to the one for non-African popula-
tions when ρ = 0.017. Therefore, the sample size deter-
mination would lead to similar results for these two
distinct populations.
In the statistical literature, there are several methods
for constructing a confidence interval for a proportion
that can be used for sample size determination, as
reviewed elsewhere [23]. The most popular method is
the so-called Wald Score that, although its simplicity of
calculation, may lead to poor coverage and problems of
overshoot and degeneracy [10]. An alternative method is
to introduce an continuity correction in the Wald Score
that, when applied to SP estimation, leads to the follow-
ing confidence interval at 95%
π^ l ¼ π^−1:96
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
π^ 1−π^ð Þ
n
r
−
1
2n
ð9Þ
and
π^ l ¼ π^ þ 1:96
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
π^ 1−π^ð Þ
n
r
þ 1
2n
; ð10Þ
where π^ is an estimate of the true SP, n is the sample size
and 1.96 is the 97.5%-quantile of a standard Gaussian dis-
tribution. For a given SCR, one can compute the expected
π using equation (8) and replace it in the above equations
in order to obtain the corresponding confidence bounds
π^ l and π^u for a given sample size n. These confidence
bounds can then be back-transformed into the corre-
sponding ones for SCR using equation (8) again. To per-
form the back-transformation, one needs to solve the
following equations as function of λl and λu (the corre-
sponding lower and upper bounds of SCR)
π^ l ¼
XAmax
t¼1
αt
λ
λþ ρ0
1−e− λþρ0ð Þt
 
; ð11Þ
and
Table 1 Expected relationship between EIR, PR04, SCR and
SP in African (AFR), Southeast Asian and South American
(SEA + SA) populations where seroreversion rate was
fixed at 0.017
EIR PR04 SCR
Seroprevalence
AFR SEA + SA
0.01 0.050 0.0036 0.057 0.073
0.10 0.073 0.0108 0.156 0.195
1.00 0.119 0.0324 0.365 0.437
10.0 0.231 0.0969 0.647 0.720
100.0 0.625 0.2900 0.860 0.896
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π^u ¼
XAmax
t¼1
αt
λ
λþ ρ0
1−e− λþρ0ð Þt
 
: ð12Þ
Unfortunately these equations can be solved analytically
but a binary searching algorithm, although slow, is able
to obtain an approximate solution using an appropriate
searching interval.
In theory, one defines the coverage of a confidence inter-
val as the number of times that confidence interval con-
tains the true value of the parameter upon repeated
sampling. Under this definition, a confidence interval at
95% should lead to a coverage of 95%. However, the ex-
pected coverage is not always achieved due to the use of
(Gaussian) approximations for the random variables under-
pinning the construction of a given confidence interval.
This putative incorrect coverage affects sample size deter-
mination by either undersampling in situations of under-
coverage or oversampling in situations of overcoverage, as
reported for proportion estimation when data stems from
populations with proportions less than 0.1 or higher than
0.9 [23,24]. Therefore, the back-transformation method
was tested against these putative coverage problems.
The expected coverage of the confidence interval for
SCR was assessed via simulation. For every pairwise com-
bination of SCR and n, the following two-step algorithm
was employed for the generation of a given data set: i)
generate the age of each individual in the sample, and (ii)
generate the corresponding serological state as a Bernoulli
trial with seropositivity probability given by equation (2).
The back-transformation of the confidence interval for SP
was applied to each data set. Coverage was finally calcu-
lated by counting how many times the confidence inter-
vals included the SCR that generated the data.
The performance of this method was also assessed in
terms of the midpoint of the corresponding confidence
interval for SCR. In this scenario, a confidence interval
was defined as central if the true SCR was located in the
middle of the corresponding interval. A practical implica-
tion of using central confidence intervals is that they have
the shortest length among all intervals one can construct
with a given confidence level if a Gaussian distribution is a
good approximation for the sampling distribution of SCR
estimates. In that case, the use of central confidence inter-
vals for sample size determination implies working with
the best precision possible and, thus, the subsequent sam-
ple sizes are the minimum ones for a given confidence
level. In opposition, if the constructed confidence intervals
are not central, they might not be the ones providing the
highest precision (i.e., with shortest length). To assess
whether a given confidence interval is or not central, one
is required to know the sampling distribution of SCR esti-
mates upon repeated sampling. Unfortunately that distri-
bution is not known in general.
Sample size determination was then conducted by given
length of the 95% confidence interval for SCR. With this
goal in mind, the relative length of that confidence interval
was fixed at a given constant (e.g., 1, 0.75, 0.5, and 0.25).
The above back-transformation method was used together
with an additional binary search method aiming to find
the required sample size. The search algorithm was imple-
mented in R software and the corresponding code is avail-
able from the authors upon request.
When there is little information on SRR to help plan-
ning a study, there is no clear analytical method to cal-
culate the required sample size. Instead, data simulation
would appear to be the best approach for the problem.
Specifically, data simulation was used to study the ex-
pected length of the confidence intervals for SCR given
a set of sample sizes (e.g., n = 250, 500, 1,000, 2,500,
5,000 and 10,000). The generation of each data set
followed the same algorithm as described for the per-
formance of the first sample size calculator. For each
generated data set, the estimates of SCR and SRR were
obtained via maximum likelihood methods. To obtain
the precision of SCR estimate associated with a given
sample size, the 2.5% and 97.5% quantiles were calcu-
lated for the set of SCR estimates generated from data of
a given transmission intensity. The absolute precision
was defined as the absolute difference between these two
quantiles whereas the relative precision is the absolute
precision divided by the SCR that generated the data.
It is worth noting that the absolute precision (pr) of
SP estimates associated with the first sample size calcu-
lator can be rewritten as a function of 1/n given a pair
of SCR and SRR, that is,
prnjρ0 π^ð Þ ¼ 3:92
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
π^ 1−π^ð Þ
n
r
þ 1
n
; ð13Þ
where the above equation results from the absolute differ-
ence between equations (9) and (10). Since this sample size
calculator is based on a back-transformation relating SP to
SCR, the precision of SCR estimates can also be expressed
by a function of 1/n (say function g). This function is
highly non linear and not analytically derivable but in the-
ory can be approximated by the following MacLaurin ex-
pansion from Mathematical Calculus:
prnjρ0 ¼ g 0ð Þ þ
g 0 0ð Þ
1!
 1
n
þ g
00 0ð Þ
2!
 1
n2
þ g
000 0ð Þ
3!
 1
n3
þ⋯ ð14Þ
where g 0 (0), g 00 (0) and g 000 (0), are unknown but fixed
constants associated with the function g, its first, second
and third derivative evaluated at zero, respectively. There-
fore, the precision of SCR estimates (λ^) can be determined
by a regression linear model as function of 1/n, that is,
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prnjρ0 λ^
 
¼ β0 þ
β1
n
þ β2
n2
þ β3
n3
; ð15Þ
where β0, β1, β2 and β3 are coefficients to be estimated
from the set of SCR estimates obtained from the simulated
data. This rationale was assumed to be applicable directly
to the second sample size calculator where SRR is un-
known. The above model was then estimated to the simu-
lated precision data via maximum likelihood method. The
resulting adjusted correlation coefficient between simu-
lated and predicted data was found to be >0.99, thus,
suggesting that the above model is indeed a good approxi-
mation of the relationship between the sample size and
the expected precision of SCR estimates. The last step was
to find the sample size associated with a given precision.
This was done numerically by using a binary search
algorithm.
Results
Performance of the back-transformation method
The performance of the back-transformation method
was first assessed in terms of the expected coverage of
the 95% confidence intervals for SCR (Table 2). In most
cases, the confidence intervals showed slight overcover-
age (≤1%) with a few exceptions. In very low transmis-
sion settings (SCR = 0.0036), the confidence intervals
show undercoverage for sample sizes ≤250 in Africa and
≤500 elsewhere, respectively. The most severe case of in-
correct coverage is for samples of 50 individuals from
African populations where a strong overcoverage (0.998)
is observed. Interestingly, in a non-African context, the
confidence intervals show instead undercoverage (0.909)
for the sample size and transmission intensity. These op-
posing results might reflect marked differences in the
underlying age structures, notably in terms of the pro-
portion of children in one population and the other (see
Figure 1C). In high transmission intensities (SCR = 0.29),
the confidence intervals also show undercoverage for
samples of 100 individuals or less in African settings. In
practice, the problem of under or overcoverage most
likely results in confidence intervals with higher or lower
length than they should in relation to a situation where
the correct coverage is obtained for the constructed in-
tervals. This has an impact on sample size determination
in the sense that controlling the length of the confidence
intervals showing these problems might lead to smaller
or greater samples sizes than required in reality.
Confidence intervals for SCR estimates were then evalu-
ated in terms of their midpoints. The results suggest that
these midpoints and the true SCR tend to be closer to each
other with the increase of the sample size (Additional file 3:
Figure A). Mathematically speaking, this results from ap-
proximating the back-transformation by means of a linear
relationship between SP and SCR. The precise sample size
where that begins to happen increases with the underlying
transmission intensity. More specifically, sample sizes of
about 400 and 2,250 individuals tend to provide central
confidence intervals when SCR=0.0036 and 0.29, respect-
ively. For moderate sample sizes, say n < 500, the back-
transformation method implies non-central confidence
intervals for intermediate values of SCR. Since the exact
distribution of SCR estimates is not known in general, it is
unclear whether these non-central confidence intervals are
the ones providing the highest precision.
Sample size calculations for known SRR
Sample size determination was then conducted under the
assumption of a known SRR (SRR = 0.017; Table 3). For
the same relative precision, the sample sizes vary with
transmission intensities. In particular, sample sizes in-
crease from very low to intermediate transmission inten-
sities and then they declined after reaching a sufficiently
high transmission intensity (i.e., when the SP curve be-
comes flat). With the increase of precision, the difference
between sample sizes from different transmission inten-
sities increases dramatically. On one extreme, for a relative
length of 1, sample sizes vary from 73 (SCR = 0.0324) to
315 (SCR = 0.0036) and from 67 to 248 in African and
non-African settings, respectively. On the other extreme,
sample sizes range from 976 to 4968 (Africa) and from
890 to 3558 (elsewhere) for a relative length of 0.25.
Similar sample sizes were found for African and non-
African populations experiencing SCR = 0.0324 and 0.0964
(intermediate transmission) irrespective of the relative
precision used. When SCR = 0.0964, the sample sizes for
African populations are 79, 127 and 262 and 976 individ-
uals to ensure a relative precision of 1, 0.75, 0.5, and 0.25,
respectively, whereas the corresponding ones for non-
African settings are 90, 142, 288 and 1,059. However,
African studies require larger sample sizes than their non-
African counterparts for SCR = 0.0036 and 0.0108 and the
Table 2 Coverage of confidence intervals based on
back-transformation algorithm assuming SRR = 0.017
Population Sample
size
Seroconversion rate
0.0036 0.0108 0.0324 0.0969 0.2900
Africa 50 0.998 0.958 0.960 0.959 0.922
100 0.930 0.948 0.950 0.951 0.937
250 0.939 0.956 0.959 0.952 0.951
500 0.958 0.952 0.956 0.955 0.957
1,000 0.954 0.958 0.955 0.957 0.951
Elsewhere 50 0.909 0.942 0.952 0.954 0.970
100 0.935 0.953 0.958 0.954 0.951
250 0.948 0.955 0.958 0.961 0.954
500 0.946 0.958 0.954 0.955 0.955
1,000 0.954 0.953 0.955 0.952 0.952
Sepúlveda and Drakeley Malaria Journal  (2015) 14:141 Page 7 of 13
Table 3 Exact sample sizes and corresponding ranges for absolute SCR, EIR and SP by controlling the relative length of
95% confidence interval for SCR under the assumption of SRR = 0.017
Population Relative length SCR Sample size SCR EIR SP
Africa 1.00 0.0036 315 0.0019-0.0054 0.00-0.03 0.030-0.085
0.0108 128 0.0058-0.0166 0.03-0.26 0.090-0.223
0.0324 73 0.0189-0.0513 0.34-2.75 0.248-0.483
0.0969 79 0.0627-0.1594 4.18-29.17 0.536-0.759
0.2900 151 0.1994-0.4885 46.5-300.58 0.801-0.919
0.75 0.0036 549 0.0023-0.0050 0.00-0.02 0.037-0.078
0.0108 220 0.0070-0.0151 0.04-0.21 0.106-0.207
0.0324 123 0.0218-0.0461 0.46-2.20 0.276-0.455
0.0969 127 0.0689-0.1415 5.08-22.76 0.560-0.735
0.2900 233 0.2137-0.4307 53.7-231.22 0.813-0.907
0.50 0.0036 1163 0.0027-0.0045 0.01-0.02 0.044-0.071
0.0108 479 0.0082-0.0136 0.06-0.17 0.123-0.190
0.0324 264 0.0250-0.0412 0.61-1.74 0.305-0.425
0.0969 262 0.0765-0.1249 6.31-17.54 0.588-0.707
0.2900 461 0.2326-0.3776 64.05-175.78 0.827-0.893
0.25 0.0036 4,968 0.0032-0.0041 0.01-0.01 0.051-0.064
0.0108 1,878 0.0095-0.0122 0.08-0.14 0.140-0.173
0.0324 1,009 0.0285-0.0366 0.81-1.36 0.335-0.396
0.0969 976 0.0858-0.1100 8.02-13.46 0.617-0.678
0.2900 1,670 0.2576-0.3301 79.28-132.89 0.843-0.877
Elsewhere 1.00 0.0036 248 0.0019-0.0055 0.00-0.03 0.039-0.107
0.0108 105 0.0059-0.0166 0.03-0.26 0.115-0.276
0.0324 67 0.0195-0.0516 0.37-2.79 0.311-0.563
0.0969 90 0.0645-0.1612 4.43-29.85 0.622-0.819
0.2900 209 0.2019-0.4915 47.71-304.46 0.853-0.940
0.75 0.0036 439 0.0023-0.0050 0.00-0.02 0.047-0.098
0.0108 179 0.0070-0.0151 0.04-0.21 0.134-0.256
0.0324 111 0.0221-0.0463 0.48-2.22 0.340-0.534
0.0969 142 0.0700-0.1426 5.26-23.12 0.643-0.798
0.2900 320 0.2154-0.4325 54.58-233.33 0.861-0.931
0.50 0.0036 953 0.0027-0.0045 0.01-0.02 0.056-0.090
0.0108 388 0.0082-0.0136 0.06-0.17 0.154-0.236
0.0324 234 0.0251-0.0413 0.62-1.75 0.371-0.503
0.0969 288 0.0771-0.1254 6.41-17.7 0.667-0.774
0.2900 629 0.2335-0.3784 64.59-176.58 0.872-0.921
0.25 0.0036 3,558 0.0031-0.0040 0.01-0.01 0.064-0.082
0.0108 1,507 0.0095-0.0122 0.08-0.14 0.175-0.216
0.0324 890 0.0286-0.0367 0.81-1.36 0.404-0.470
0.0969 1,059 0.0859-0.1101 8.04-13.49 0.693-0.748
0.2900 2,263 0.2579-0.3304 79.44-133.1 0.884-0.909
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other way around for SCR = 0.29. For the same transmis-
sion intensity, the requirement of a smaller or larger sam-
ple size in African studies in the relation to others
conducted elsewhere reflects the steepness of the SCR-SP
curve. In other words, the use of the back-transformation
implies that, when specifying a given confidence interval
for SP, the confidence interval for SCR is going to be
narrower or wider depending on the steepness of the SP
curve. Mathematically, the steepness of that curve is given
by the respective derivative. That derivative was found to
be smaller in African than in non-African populations
for SCR < 0.058 and the other way around for SCR > 0.058
(Additional file 3: Figure B). Available PR data for P. falcip-
arum suggests that non-African populations are most
likely to be at lower endemicity [25]. Note that, for SCRs
in the vicinity of 0.058 where the two derivative func-
tions cross each other, it is expected to obtain similar
sample sizes for both populations, a result compatible
with the sample sizes provided for intermediate trans-
mission intensities. Finally, the relationship between
SCR and SP was here found to be similar between
Africa and non-African populations when SRR = 0 and
0.017, respectively (Figure 1D). Therefore, the com-
parison between sample sizes for African and non-
African studies can also be used to ascertain the bias
in sample size estimates when assuming SRR = 0 in an
African setting.
The calculated sample sizes can also be used to help
designing studies including different populations (or
sites). Firstly, there is no theoretical impediment to use
distinct sample sizes for populations known to differ in
malaria endemicity. For example, a sample size of
approximately 125 individuals will provide a relative
precision of 1 for African sites experiencing a SCR of
0.0108. The same sample size leads to a relative precision of
0.75 for African populations with SCR = 0.0324 or 0.0969.
Secondly, the expected confidence intervals for SCR can
also provide clear insights on the underlying statistical
power to compare sites with different transmission inten-
sities. In particular, the sample sizes associated with a rela-
tive precision of 1 are enough to distinguish sites differing
at least one order of magnitude in EIR with 95% confi-
dence (or with 5% significance level in hypothesis testing
terminology). However, this distinction cannot be done if
these sample sizes were used and a 99% confidence level
was alternatively specified to study between any two sites
differing exactly one order of magnitude (Additional file
4). Thirdly, the expected confidence intervals for SCR are
alternatively instrumental to know which transmission
intensity range cannot be discriminated by the data.
For example, a sample size of 79 individuals associated
with a relative length of 1 and SCR = 0.0969 cannot
distinguish African populations with EIR ranging from
4.18 to 29.17.
Sample size calculations for unknown SRR
Sample size calculations were then performed for the most
common situation of unknown SRR. For low transmission
settings (SCR ≤ 0.0108) and reasonably low sample sizes,
there is a non-negligible probability of generating data sets
leading to null SRR estimates (Table 4). More precisely,
for SCR = 0.0036, one would need to sample at least 1,000
individuals to ensure that chance is smaller than 10%
whereas for SCR = 0.0108, the same is achieved for sample
sizes of no less than 500 individuals. In practice, these
problematic data sets imply that the corresponding SCR
estimates underestimate the true SCR that generated the
data (Table 4). This underestimation can be explained by
the fact that just a few seronegative individuals may result
from seroreversion events but they are wrongly assumed
to have never been exposed to malaria parasites under a
null SRR estimate. For higher transmission settings, the
occurrence of these problematic data sets is minimal be-
cause the generated data has a good balance between the
total number of seropositive and seronegative individuals.
Approximated sample sizes were calculated using data
simulation coupled with a regression model relating pre-
cision to sample size (Table 5); see Additional file 5 for
the respective simulation results. Three key observations
can be highlighted. Firstly, as found for known SRR, the
same qualitative behavior between sample size and
transmission intensity was found irrespective of the
population under study. More precisely, the sample sizes
increase from very low to moderate transmission and
decrease from then on. Secondly, the necessity of esti-
mating an additional parameter from the data brought
Table 4 Percentage of simulated data sets where SRR was
estimated as 0 (%ρ=0) and the bias of the corresponding
SCR estimates taken as the percentage in relation to the
true SCR
Population Sample
size
SCR = 0.0036 SCR = 0.0108
%ρ=0 Bias (%) %ρ=0 Bias (%)
Africa 250 28.6 −25.7 16.0 −26.1
500 21.9 −25.3 8.4 −26.6
1,000 13.1 −25.6 2.0 −25.6
2,500 3.7 −25.2 0.1 −26.4
5,000 0.6 −24.4 0.0 N/A
10,000 <0.1 −22.4 0.0 N/A
Elsewhere 250 27.0 −29.6 14.6 −30.5
500 20.1 −29.4 6.1 −30.2
1,000 11.2 −29.2 1.5 −30.7
2,500 3.0 −28.6 <0.1 −32.2
5,000 0.4 −28.8 0.0 N/A
10,000 0.0 N/A 0.0 N/A
Bias was defined as the difference between the mean of the corresponding
estimates and the true value of SCR. The true SRR that generated the data sets
was fixed at 0.017.
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more uncertainty over SCR estimation, thus, increasing
the previous sample sizes for known SRR. In this case,
the difference in sample sizes assuming or not a known
SRR decreases with transmission intensity. On one ex-
treme, for SCR = 0.0036, the sample sizes for relative
precisions of 1, 0.75, 0.50 and 0.25 are now 2,193, 5,127
and >10,000, respectively, in comparison to 315, 549,
1163 and 4968 assuming a known SRR. On the other ex-
treme, for SCR = 0.29, the sample sizes do not differ sub-
stantially assuming or not known SRR: 213, 267, 542,
and 1,927 (unknown SRR) versus 151, 233, 461, and
1,670 (known SRR). Thirdly, for the same relative preci-
sion, African studies are most likely to require lesser in-
dividuals than their counterparts conducted elsewhere.
This is in clear contrast to above results for known SRR
where African studies would only have decreased sample
sizes in high transmission intensities. The explanation
for this result is unclear but it might be related again to
the underlying age distribution. When SRR is unknown,
the bulk of the information on SCR seems to come from
young individuals and, if so, African populations have a
higher proportion of individuals with that age. Finally, it
is worth noting that, since the sample sizes were calcu-
lated using the same relative precision, the above-
mentioned results for known SRR on comparing African
to non-African studies are still valid for unknown SRR.
Discussion
In this paper, two sample size calculators for estimating
antibody SCR were proposed. The first calculator is
based on the assumption of known SCR and, because of
that, it implies smaller sample sizes in relation to a situ-
ation where SCR is assumed to be unknown. Obtaining
smaller sample size is important for studies where eth-
ical issues, limited human and economic resources, or
time constraints might be in place. However, this calcu-
lator requires fixing SRR at a given constant. In this re-
gard, the current knowledge of SRR is still limited.
Firstly, this parameter has only been measured indirectly
by means of fitting the reverse catalytic models to data.
Secondly, there might be age differences in seroreversion
but seropositivity data appears to not have enough infor-
mation for its detection [1]. Therefore, considering SRR
at a fixed constant is a pragmatic choice not also for
data analysis but also for sample size calculation. Not-
withstanding this pragmatism, current estimates of SRR
[1,7,13] are of the same of magnitude of the one used
here and, therefore, the calculated sample sizes would
appear to be reliable in general. However, for the matter
of precision, sample size determination is recommended
to be performed using a predefined SRR estimate from a
reliable source. An obvious source of information can be
data from another population but with similar malaria
transmission intensity and host factors. Another possible
source of information is to use existing data from past
surveys taken from the same population, as reported in
a recent study from Kenya [26]. Statistically speaking, a
more coherent and elegant way to incorporate prior in-
formation in sample size determination is via Bayesian
methodology as done elsewhere for estimating propor-
tions (or prevalences) [27,28]. Although appealing, this
approach would not appear to attract much attention
of malaria epidemiologists, as suggested by the scarce
number of studies applying such alternative approach
to data analysis.
The basic idea underlying the first sample size calcula-
tor is to apply a back-transformation to the confidence
interval for SP. The reliability of this method is then
critically dependent not only on the statistical perform-
ance of the chosen SP confidence interval (in this case,
the Wald Score corrected for continuity), but also on
the degree of similarity between the age distribution
used in the sample size determination and the one to be
obtained upon sample collection. In terms of the Wald
confidence interval using a continuity correction, it is
one among more than twenty methods proposed to con-
struct confidence interval for a proportion [23]. A recent
study compared seven of these methods in terms of
Table 5 Approximate sample sizes for controlling
precision of SCR estimates under of the assumption of
unknown SRR where the true SRR was fixed at 0.017
Relative length SCR
Sample size
Africa Elsewhere
1.00 0.0036 1,340 1,487
0.0108 507 563
0.0324 228 248
0.0969 201 204
0.2900 213 298
0.75 0.0036 2,193 2,414
0.0108 871 980
0.0324 323 379
0.0969 240 285
0.2900 267 474
0.50 0.0036 5,127 5,803
0.0108 1,759 1,974
0.0324 784 918
0.0969 447 615
0.2900 542 938
0.25 0.0036 >10,000 >10,000
0.0108 7,910 8,461
0.0324 2,676 3,077
0.0969 1,746 2,077
0.2900 1,927 3,057
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sample size determination for estimating a proportion
[10]. General guidelines are not easy to put forward be-
cause they depend not only on the different criteria on
how to deal with eventual problems of under or over-
coverage of the corresponding confidence intervals, but
also on the underlying proportion of the population
under study. Notwithstanding this problem, these au-
thors showed that, for a given absolute precision and a
proportion between 0.01 and 0.90, the sample sizes from
different methods do not deviate more than 40 sampling
units. This result is expected to hold true for SCR esti-
mation, but might require large-enough sample sizes
where a linear approximation can be invoked between
SCR and SP. With the respect to the age distributions
used here, official statistics showed a clear distinction
between African and non-African populations. However,
these age distributions report to the respective overall
populations and, thus, slight differences are expected to
be seen between these whole-population-based distribu-
tions and the corresponding ones for the rural areas
where malaria is more prevalent. Although a case-by-
case approach is recommended, these differences are
most likely to be related to a higher number of older in-
dividuals living in urban population that, in general, have
better access to health care. Other factors related to
sampling feasibility might also introduce some bias in the
sampled age distribution, such as using schools surveys or
collecting household-consented data that led to a slightly
overrepresentation of school-aged children (5–18 years
old) in recent studies [9,29,30]. Notwithstanding these pu-
tative differences between official and sampled age distri-
butions, there is a good agreement between the age
distributions used here and the ones found across a series
of recent cross-sectional studies [31-33]. Thus, the calcu-
lated sample sizes would appear to be reliable for planning
future surveys not using age stratification. A natural follow
up of this work is then to perform sample size determin-
ation on alternative sampling strategies that may necessi-
tate targeting or oversampling specific age groups. In
theory, stratified sampling, if done intelligently, is known
to improve precision of the ensuing estimates of the popu-
lation prevalence [34]. Since the first sample size calculator
is based on the confidence interval for SP, the sample sizes
of age-adjusted sampling strategies should be decreased in
relation to the ones calculated here. The optimal age strati-
fication in terms of minimum sample size is one among
other questions to be explored in a near future.
The second sample size calculator relates to the most
general situation of a unknown SRR. Although general,
this method only provides approximate sample sizes be-
cause it uses simulation coupled with a regression model
predicting the expected precision as function of the sam-
ple size. As expected, the additional requirement of esti-
mating SRR results in larger sample sizes in comparison
to the ones derived from a known SRR. The simulation
results highlighted the possibility of generating data sets
from low transmission settings where one does not have
enough information to estimate the SRR, thus, introdu-
cing significant negative biases on the SCR estimates. To
minimize the occurrence of such situations, sample sizes
of no less than 1,000 and 500 are recommended for
EIR = 0.01 and 0.1, respectively. It is worth noting that
there are many combinations of transmission intensities
and relative precisions leading to sample sizes of more
than 1,000 individuals. This relatively intensive sampling
is particularly important for studying populations close
to malaria elimination (SCR ≤ 0.0108). As a statistical ad-
vantage, a large sample size diminishes the chance of
underestimating SCR due to null SRR estimates. How-
ever, large community-based surveys are usually seen as
financially and logistically demanding enterprises and
school or health centre surveys may be more pragmatic.
As with a conventional metric like parasite rate, the rela-
tive advantages and disadvantages of a relatively small
community-based survey and a large study using a more
convenient sampling approach need to be properly bal-
anced. Additionally the simulation algorithm for calcu-
lating precision assumes a population of infinite size.
This assumption is reasonable in highly dense popula-
tions living in small areas where malaria transmission is
expected to be more homogeneous. However, this is un-
common with heterogeneity in population density and
malaria transmission more likely to be the norm espe-
cially at low transmission. The corresponding sample
size will need to be inflated if one is to unravel subpopu-
lations with subtle differences in malaria exposure, as
observed in different studies [1,7,13]. Finally, a large
sample size might not be feasible in intrinsically small
populations, such as the ones living in islands [4,9]. In
that case, the precision is in fact increased in relation to
the one calculated from infinite-size population and,
thus, the proposed sample size calculator would lead to
oversampling. However, if there are no dramatic cost re-
strictions, oversampling might overcome eventual losses
of precision due to the occurrence of missing data.
It is also important highlighting the fact that the SCR
and SRR used here are for the merozoite surface protein-1
(MSP1) antigen. Another well-characterized antigen is
the P. falciparum apical membrane antigen-1 (AMA1).
Current SCR and SRR estimates are different for these
two antigens due to their inherent immunogenicity and
half-life exposed to the immune system [8] with a higher
SCR for AMA1 compared to its MSP1 counterpart. As a
direct consequence of this observation, smaller sample
sizes will be required for AMA1-based studies. There is
relatively little data for other antigens though variation in
seroconversion rates has been reported [35,36]. Practically
to overcome issues around antigenic variation and
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differential population reactivity (e.g., due to genetics), a
combination of antigens are used and sample sizes would
be derived from the most immunogenic component.
In conclusion, this paper described relatively straight-
forward approaches to calculating the sample size for es-
timating SCR. The methods assume data derived from
areas with stable transmission, standard population age
distributions and community-based surveys with no age
stratification. Several caveats relating to survey design,
antibody reversion rates and antigen choice were pre-
sented to allow an appreciation of the complexity of the
issue. Pragmatically however, the results suggest that
SCR estimation can be readily incorporated into the de-
sign of most malariometric studies and this will be of
particular use in populations with low malaria endem-
icity. Further work is needed to assess the sample size
requirements for estimating any change in transmission
with serology.
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